DUBLIN, July 07, 2015 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/q25sz4/microfluidics) has announced the addition of the "Microfluidics Market by Material (Polymer, Glass, Silicon) Application (Pharmaceutical (Genomics, Proteomics, Capillary Electrophoresis) Diagnostic (Clinical, Environmental, Industrial) Drug Delivery (Inhaler, Micropump)) - Global Forecast to 2020" report to their offering.
The global microfluidics market is valued at $3 Billion in 2015 and is poised to grow at a CAGR of 19% during the forecast period (2015 to 2020).
This market is mainly driven by the rising demand for point-of-care (POC) testing, increasing demand for microfluidic chip miniaturization as it offers lower testing time and improved portability, growing Asian market, rising incidences of lifestyle diseases, increasing R&D expenditure and healthcare spending, and growing stem cell and cancer research. However, complex and time-consuming regulatory approval process, high cost of integrated instruments and microfluidic sensors, and lack of market visibility for microfluidics products are inhibiting the growth of this market to a certain extent.
The global microfluidics market is segmented on the basis of materials and applications. On the basis of materials, the market is categorized into polymer-based microfluidics, glass-based microfluidics, silicon-based microfluidics, and other material-based microfluidics.
On the basis of applications, the microfluidics market is divided into pharmaceutical research, in vitro diagnostics, and drug delivery. The pharmaceutical research segment is further segmented into lab analytics (cell-based assays, proteomic analysis, genomic analysis, and capillary electrophoresis), dispensing, and microreaction.
The in vitro diagnostics application segment is further divided into clinical diagnostics, point-of-care testing, environmental testing, industrial testing, and agro food testing. The drug delivery application segment is divided into inhalers, microneedles, and micropumps.
In 2014, the in vitro diagnostics application segment accounted for the largest share of the global microfluidics market, primarily owing to the rising incidences of chronic diseases, growing demand for point-of-care testing, and rising aging population.
North America accounted for the largest share in 2014, followed by Europe, Asia-Pacific, and RoW. The Asia-Pacific region represents the fastest-growing market for microfluidics products, primarily due to the increasing R&D and healthcare expenditure and growth in the overall healthcare industry. In addition, increasing investments in the healthcare industry by key market players, rising demand for cutting-edge technologies, and expansion of private sector hospitals to rural areas in countries such as China, Taiwan, and India are driving the growth of this region.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 Global Microfluidics Market, By Material
8 Microfluidics Market, By Application
9 Global Microfluidics Market, By Region
10 Competitive Landscape
11 Company Profiles
- Agilent Technologies, Inc.
- Becton, Dickinson And Company
- Bio-Rad Laboratories, Inc.
- Cepheid Inc.
- Danaher Corporation
- Fluidigm Corporation
- Illumina, Inc.
- Perkinelmer, Inc.
- Roche Diagnostics Ltd.
- Thermo Fisher Scientific, Inc.
For more information visit http://www.researchandmarkets.com/research/q25sz4/microfluidics
Media Contact: Laura Wood , +353-1-481-1716, firstname.lastname@example.org
SOURCE Research and Markets